Sverige - svenska - Läkemedelsverket (Medical Products Agency)

ebb medical ab - propranololhydroklorid - filmdragerad tablett - 10 mg - propranololhydroklorid 10 mg aktiv substans; glycerol hjälpämne; laktosmonohydrat hjälpämne

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

vetoquinol sa - fenylpropanolaminhydroklorid - sirap - 50 mg/ml - sorbitol hjälpämne; fenylpropanolaminhydroklorid 50 mg aktiv substans - fenylpropanolamin - hund

Europeiska unionen - svenska - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - läkemedel som används vid diabetes - type 2 diabetes mellitusedistride is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillägg till andra läkemedel för behandling av typ 2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 och 5. heart failureedistride is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseedistride is indicated in adults for the treatment of chronic kidney disease.

Europeiska unionen - svenska - EMA (European Medicines Agency)

astrazeneca ab - dapagliflozin propandiolmonohydrat - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - läkemedel som används vid diabetes - type 2 diabetes mellitusforxiga is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance. i tillägg till andra läkemedel för behandling av typ 2-diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 och 5. heart failureforxiga is indicated in adults for the treatment of symptomatic chronic heart failure. chronic kidney diseaseforxiga is indicated in adults for the treatment of chronic kidney disease.

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris ab - fenylpropanolaminhydroklorid - depottablett - 25 mg - fenylpropanolaminhydroklorid 25 mg aktiv substans; laktosmonohydrat hjälpämne; glycerol 85% hjälpämne - fenylpropanolamin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

viatris ab - fenylpropanolaminhydroklorid - depottablett - 50 mg - laktosmonohydrat hjälpämne; glycerol 85% hjälpämne; fenylpropanolaminhydroklorid 50 mg aktiv substans - fenylpropanolamin

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

orifarm ab - metoprololsuccinat - depottablett - 100 mg - sockersfärer hjälpämne; metoprololsuccinat 95 mg aktiv substans

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva sweden ab - metoprololsuccinat - depottablett - 100 mg - metoprololsuccinat 95 mg aktiv substans; sockersfärer hjälpämne - metoprolol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva sweden ab - metoprololsuccinat - depottablett - 200 mg - metoprololsuccinat 190 mg aktiv substans; sockersfärer hjälpämne - metoprolol

Sverige - svenska - Läkemedelsverket (Medical Products Agency)

teva sweden ab - metoprololsuccinat - depottablett - 25 mg - metoprololsuccinat 23,75 mg aktiv substans; sockersfärer hjälpämne - metoprolol